July 15, 2016
HIV and TB
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development
Written by Polly Clayden, Simon Collins, Mike Frick, Mark Harrington, Tim Horn, Richard Jefferys, Erica Lessem, and Lindsay McKenna
In this year’s report:
General
HCV
HIV
Full PDF of 2016 Pipeline Report
2016
The Antiretroviral Pipeline
July 2016
Fit For Purpose: Antiretroviral Treatment Optimization
July 2016
The Pediatric Antiretroviral Pipeline
July 2016
Preventive Technologies: Antiretroviral and Vaccine Development
July 2016
Research Toward a Cure and Immune-Based and Gene Therapies
July 2016
2016
The Antiretroviral Pipeline
July 2016
Fit For Purpose: Antiretroviral Treatment Optimization
July 2016
The Pediatric Antiretroviral Pipeline
July 2016
Preventive Technologies: Antiretroviral and Vaccine Development
July 2016
Research Toward a Cure and Immune-Based and Gene Therapies
July 2016
TB
Full PDF of 2016 Pipeline Report
2016
The Tuberculosis Diagnostics Pipeline
July 2016
The Tuberculosis Prevention Pipeline
July 2016
The Tuberculosis Treatment Pipeline: Activity, but No Answers
July 2016
The Pediatric Tuberculosis Treatment Pipeline: Beyond Pharmacokinetics and Safety Data
July 2016
2016
The Tuberculosis Diagnostics Pipeline
July 2016
The Tuberculosis Prevention Pipeline
July 2016
The Tuberculosis Treatment Pipeline: Activity, but No Answers
July 2016
The Pediatric Tuberculosis Treatment Pipeline: Beyond Pharmacokinetics and Safety Data
July 2016